Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 67,400 shares, a drop of 50.0% from the June 15th total of 134,800 shares. Approximately 2.0% of the company’s stock are sold short. Based on an average daily volume of 277,800 shares, the short-interest ratio is currently 0.2 days.

Silo Pharma Price Performance

SILO traded up $0.03 during trading on Friday, reaching $1.01. 85,241 shares of the stock traded hands, compared to its average volume of 185,639. Silo Pharma has a fifty-two week low of $0.84 and a fifty-two week high of $3.05. The stock’s 50-day simple moving average is $1.44 and its two-hundred day simple moving average is $1.59.

Silo Pharma (NASDAQ:SILO) last released its quarterly earnings data on Monday, May 13th. The company reported ($0.28) earnings per share (EPS) for the quarter. Silo Pharma had a negative net margin of 4,992.30% and a negative return on equity of 51.75%. The firm had revenue of $0.02 million for the quarter.

Silo Pharma Company Profile

Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.